Clinical Trial Update: Teriparatide for Fracture Repair in Humans [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating teriparatide for fracture repair in patients with osteoporosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Humeral Fracture
• Osteoporosis

Drugs mentioned

• Teriparatide (Forteo) (teriparatide)

Snippet

Sponsor: Medical University of Vienna | Conditions: Osteoporosis, Age-Related, Humeral Fractures | Phase 3 | Status: WITHDRAWN